Women's HealthAPI · DT56a
Femarelle®
A non-hormonal botanical line supporting women across estrogen-decline stages — 40+, 50+ and 60+. Declared 1st line treatment for menopause management at the European Society of Gynecology, 2017.
Learn moreBotanical · Pharmaceutical · Since 1997
Balancing nature with science to produce innovative therapies.
Se-cure is a research-driven pharmaceutical company that develops proprietary botanical APIs with functionally selective mechanisms — safe, effective, and targeted.
Botanical Origin
Proprietary plant-derived APIs
Selective Mechanism
Targeted tissue activity
1st Line Treatment
Endorsed by medical societies
Global Brands
Distributed worldwide
Who we are
A discovery platform rooted in plants, refined by science.
Founded in 1997, Se-cure has built a proprietary platform for the discovery, development and scaling of therapies from botanical origin — introducing novel biochemical agents characterised by functionally selective mechanisms of action in target tissues.
27+
Years of research
cGMP
Production facility
2017
Declared 1st line therapy
Global
International distribution
Our technology
Developing innovative botanical therapies.
Our expertise lies in creating APIs that selectively target specific tissues without affecting unwanted ones — enabling long-term, safe and effective therapies.
- Proprietary raw-material standardization
- In-line analytical & bio-chemical controls
- Finished product release criteria
Products in market
Targeted, plant-derived therapies.
Men's Urinary HealthAPI · SC012
Brizo®
A botanical therapy from the soybean plant, selectively targeting the prostate gland to relieve overactive bladder symptoms — typically within the first month of use.
Learn morePartnership
Be part of our family.
Proven international success, attractive marketing materials and professional support — built on years of expertise and many success stories.